Unit 4: Production and Formulation of Biopesticides

I. Orientation: Microbial Biopesticides as Viable Biological Products

Microbial biopesticides are preparations containing microorganisms or their biologically active products that suppress plant pathogens, insects, nematodes, or weeds. Common agents include Trichoderma, Pseudomonas, Bacillus, Beauveria, Metarhizium, Bacillus thuringiensis (Bt), and nucleopolyhedroviruses. Successful production must preserve identity, purity, viability, infectivity or antagonistic activity, while formulation must deliver the agent to the target in a stable and usable form.

• Biological nature: The active ingredient may be living cells, spores, conidia, viral occlusion bodies, or microbial metabolites; unlike many chemicals, its performance depends on biological viability and environmental conditions.
• Mode of action: Control may involve competition, antibiosis, parasitism, predation, induced systemic resistance, toxin production, or insect infection.
• Production sequence: A standard process proceeds through strain selection, maintenance of a pure stock culture, inoculum development, multiplication, harvesting, quality testing, formulation, packaging, and storage.
• Aseptic operation: Media, vessels, carriers, water, and instruments must be sterilized or appropriately disinfected to prevent contaminants from competing with the production organism.
• Quality attributes:
  • Identity: The organism must match the authenticated production strain.
  • Purity: Contaminating microorganisms must remain within applicable product standards.
  • Potency: Measured as colony-forming units (CFU), viable spores, viral occlusion bodies, infective units, or biological activity.
  • Stability: Acceptable activity must persist throughout the declared shelf life.
• Process specificity: Temperature, pH, aeration, moisture, and nutrient requirements differ among bacteria, fungi, and viruses; no single production condition suits all agents.
• Biosafety principle: Production strains should be non-pathogenic to humans, crops, and beneficial organisms when used as directed, and waste must be decontaminated before disposal.
• Field-delivery principle: A high laboratory count alone is insufficient; the formulation must permit survival, application, establishment, and activity at the target site.

II. Mass Production — Multiplication of the Microbial Active Ingredient

A. Mass production of microbial biopesticides using standard laboratory methods

Mass production is the controlled multiplication of an authenticated microbial strain to obtain a concentrated, pure, viable, and biologically active biomass or propagule preparation.

• Strain selection and authentication: An isolate is selected for strong biocontrol activity, genetic stability, rapid growth, suitability for inexpensive substrates, and tolerance to processing.

  • Identity may be checked using colony and microscopic morphology, biochemical tests, species-specific molecular markers, or sequencing.
  • Activity is confirmed by assays such as inhibition of a plant pathogen, insect mortality, or suppression of disease symptoms.

• Stock-culture system: A master culture is maintained with minimal subculturing, while a working culture supplies routine production inoculum.

  • Short-term maintenance may use agar slants at refrigeration temperature.
  • Long-term preservation commonly uses cryopreservation or lyophilization, depending on the organism.
  • Each transfer is labelled with strain code, medium, date, passage number, and operator.

• Medium preparation: The medium provides carbon, nitrogen, minerals, vitamins, and water in forms suited to the organism.

  • Bacteria such as Bacillus and Pseudomonas are commonly multiplied in nutrient-rich liquid media.
  • Fungi such as Trichoderma, Beauveria, and Metarhizium may be grown in liquid media or on sterilized grains and other solid substrates.
  • Medium pH is adjusted before sterilization because pH affects nutrient availability, growth, sporulation, and metabolite production.

• Sterilization and aseptic inoculation: Culture media and heat-stable equipment are usually autoclaved, while heat-sensitive solutions may be membrane-filtered.

  • Inoculation is performed near a flame or in a laminar-airflow cabinet using sterile loops, pipettes, flasks, and closures.
  • Negative uninoculated controls help reveal contamination originating from media or handling.

• Inoculum development: A young, actively growing starter culture is increased stepwise before entering the main production vessel.

  • The sequence may progress from agar culture to seed flask and then to fermenter.
  • A defined inoculum size reduces lag time and gives more reproducible growth.
  • Excessively old inoculum may contain damaged cells or spores with reduced germination.

• Submerged fermentation: The microorganism grows in a stirred or aerated liquid nutrient medium.

  • Control variables: Temperature, pH, agitation, aeration, dissolved oxygen, foam, and fermentation time are monitored.
  • Advantages: Conditions are readily controlled, sampling is convenient, and scale-up is comparatively systematic.
  • Limitations: Equipment and energy costs are higher; some fungi produce mycelial biomass rather than durable aerial conidia.

• Solid-state fermentation: The microorganism grows on moist solid material with little free water.

  • Sterilized rice, sorghum, millet, wheat bran, or similar substrates can support fungal growth and sporulation.
  • Moisture must support growth without producing waterlogging and poor aeration.
  • This method often yields robust fungal conidia but may show uneven temperature, moisture, and colonization.

• Organism-specific production:

  • Bacillus fermentation is managed to obtain vegetative biomass, endospores, or—in Bt production—spores and insecticidal crystal proteins.
  • Pseudomonas products generally require preservation of viable vegetative cells because they do not form endospores.
  • Entomopathogenic fungi are harvested as conidia, blastospores, or other infective propagules.
  • Insect viruses require multiplication in susceptible host insects or validated cell systems because viruses cannot reproduce in ordinary cell-free media.

• Harvesting and concentration: Biomass is recovered when the desired cell count, spore yield, or biological activity reaches its optimum.

  • Broth-grown cells or spores may be separated by centrifugation, filtration, sedimentation, or membrane concentration.
  • Solid substrates may be dried under controlled conditions, sieved, and separated from spores.
  • Excessive heat, shear, desiccation, or ultraviolet exposure can reduce viability.

• Production measurement: Viable count is commonly expressed as CFU per millilitre or gram.

CFU/mL = (colonies counted × dilution factor) / volume plated in mL

Here, colonies counted is the number appearing on the selected plate, dilution factor is the reciprocal of the plated dilution, and volume plated is the inoculated volume.

• Worked example: If 86 colonies develop from 0.1 mL of a (10^{-6}) dilution:

CFU/mL = (86 × 10^6) / 0.1 = 8.6 × 10^8 CFU/mL

Plates with confluent growth or very few colonies are unsuitable for a dependable estimate.

B. Process control, quality assurance, and limitations

Process control ensures that high biomass yield is accompanied by purity, potency, reproducibility, and safety.

• In-process monitoring: Samples are examined for pH, microscopic appearance, viable count, sporulation, germination, contamination, and target biological activity.
• Purity testing: Streak plating on suitable media can reveal mixed colony types; microscopy can detect abnormal cells, foreign spores, yeasts, or bacterial contamination.
• Potency testing: Viable count should be supplemented by a bioassay because CFU does not directly measure toxin production, virulence, rhizosphere competence, or disease suppression.
• Scale-up limitation: Conditions that perform well in a shake flask may not transfer directly to a large fermenter because oxygen transfer, mixing, heat removal, and shear change with vessel size.
• Batch documentation: Records should identify strain, substrate lot, sterilization cycle, inoculum, operating conditions, harvest date, yield, test results, and disposition.
• Waste management: Spent medium, contaminated cultures, and disposable materials are autoclaved or treated by an approved decontamination procedure before disposal.

III. Formulation — Conversion into a Stable and Deliverable Product

A. Formulation of microbial biopesticides using standard laboratory methods

Formulation combines the microbial active ingredient with carriers and additives that maintain activity during storage, transport, dilution, and field application.

• Formulation objectives: A suitable product protects the organism from moisture extremes, oxidation, heat, ultraviolet radiation, and contamination while allowing easy measurement, mixing, and application.

• Solid carrier formulations: Microbial biomass is blended with a sterile, finely divided carrier such as talc, kaolin, peat, lignite, starch, or another validated material.

  • The carrier should be non-toxic, chemically compatible, inexpensive, readily available, and capable of supporting acceptable shelf life.
  • Wettable powders must disperse in water; granules are useful for soil placement; dusts are applied directly but may drift.
  • Particle size and moisture are controlled because coarse particles obstruct equipment and high moisture accelerates deterioration.

• Liquid formulations: Cells or spores are suspended in water-based or oil-based systems containing compatible stabilizers.

  • Suspensions are easier to measure and may avoid dust during handling.
  • Oils can improve adhesion and reduce evaporation for some entomopathogenic fungi.
  • Sedimentation, oxygen limitation, viscosity, and contamination must be controlled.

• Common additives:

  • Dispersants and surfactants: Promote uniform suspension and wetting of plant or insect surfaces.
  • Stickers and binders: Materials such as compatible polymers or gums improve adhesion to seed, foliage, or granules.
  • Humectants and protectants: Glycerol, sugars, proteins, or similar validated substances may reduce desiccation injury.
  • UV protectants: Approved pigments or light-screening materials can protect susceptible spores and viruses.
  • Antifoaming or anti-caking agents: Improve processing and handling without inhibiting the microorganism.

• Standard solid-formulation procedure: The carrier is dried, sieved, sterilized or decontaminated, cooled, and aseptically mixed with concentrated culture.

  • Moisture is adjusted to a safe level for viability and storage.
  • Mixing must distribute the active ingredient uniformly without excessive heat or shear.
  • The product is filled into clean, moisture-resistant, labelled containers.

• Standard liquid-formulation procedure: Concentrated biomass is mixed aseptically with a sterile formulation base and compatible additives.

  • pH, viscosity, microbial count, and physical homogeneity are checked.
  • Containers require adequate seal integrity and appropriate headspace because leakage, gas formation, or oxygen shortage can damage quality.

• Formulation calculation: The concentration after mixing follows the mass-balance relationship:

C₁V₁ = C₂V₂

C₁ is the viable concentration of the stock, V₁ the stock volume used, C₂ the required final concentration, and V₂ the final product volume.

• Worked example: To prepare 10 L at (1 × 10^8) CFU/mL from a stock of (5 × 10^9) CFU/mL:

V₁ = (C₂V₂) / C₁
   = [(1 × 10^8) × 10] / (5 × 10^9)
   = 0.2 L

Thus, 0.2 L of stock is incorporated and the formulation base is added to a final volume of 10 L.

B. Product evaluation, packaging, storage, and limitations

Evaluation establishes whether the formulated product remains physically usable, biologically effective, and microbiologically acceptable.

• Release tests: Typical tests include appearance, pH, moisture, particle size, suspensibility, wettability, viable count, spore germination, contaminant load, and bioefficacy.
• Stability testing: Samples stored under specified conditions are tested periodically; shelf life ends when viability, activity, or physical properties fall below the accepted specification.
• Packaging: Containers should resist moisture, light, oxygen entry, leakage, and mechanical damage according to the formulation’s sensitivity.
• Labelling: The label should identify the organism and strain, viable potency, batch number, manufacture and expiry dates, storage conditions, application directions, and safety precautions.
• Storage: Cool, dry, shaded conditions generally slow viability loss, but the exact temperature depends on the organism and formulation.
• Compatibility limitation: Tank mixing with fungicides, bactericides, strongly alkaline materials, or incompatible fertilizers may kill or inhibit the active microorganism.
• Environmental limitation: Desiccation, intense sunlight, unsuitable temperature, low humidity, and absence of the target host can reduce field performance despite acceptable laboratory quality.
• Central requirement: Formulation cannot compensate for a weak, contaminated, or genetically unstable culture; dependable products require quality control from master culture through final application.